partnering

News

engineering and genetic editing through the Crispr technique. DNA chain breaking down. 3D rendering

Dyno attracts $1.6bn gene therapy deal with Astellas

Astellas has signed another bolt-on deal to build its gene therapy pipeline, agreeing a deal with Dyno Therapeutics to tap into its adeno-associated virus (AAV) vector platform for deliveri

News

GSK pumps £30m into a new Oxford University partnership

GlaxoSmithKline has formed a five-year partnership with Oxford University to set up a new institute that will apply machine learning and functional genomics to the discovery of new medicine

News

Close Up Of Senior Man Suffering With Parkinsons Diesease

Novartis takes aim at risky Parkinson's target with $1.5bn U...

Novartis has licensed a potential drug for Parkinson's from Belgium's UCB that it thinks could be the first oral, disease-modifying drug for the disease – if it can avoid the fate of earlie

News

GSK aims at NASH target with $1bn-plus Arrowhead alliance

GlaxoSmithKline has joined the ranks of drugmakers trying to develop new drugs for non-alcoholic steatohepatitis (NASH) – a condition with no approved therapies and a lengthy list of failed

News

Gilead foregoes buyout, but pledges $725m to Arcus' cancer d...

Gilead Sciences has forged closer ties to its cancer drug partner Arcus Biosciences , although a licensing deal doesn't go as far as the takeover that some market commentators have been pre

News

AI specialist Owkin snares $270m alliance with Sanofi in onc...

Sanofi has made another investment in artificial intelligence, taking a $180 million equity stake in Franco-US startup Owkin with another $90 million in funding for a program to seek out ne

Dyno attracts $1.6bn gene therapy deal with Astellas

GSK pumps £30m into a new Oxford University partnership

Novartis takes aim at risky Parkinson's target with $1.5bn U...

GSK aims at NASH target with $1bn-plus Arrowhead alliance

Gilead foregoes buyout, but pledges $725m to Arcus' cancer d...

AI specialist Owkin snares $270m alliance with Sanofi in onc...

ASCO 2026: AbbVie on ADCs, chemotherapy, and the future of o...

Discover a new era of healthcare panel engagement: Grounded ...

partnering

Editor's Picks